Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1 and RC-14:
• Help to maintain or restore healthy vaginal flora that are important in maintaining vaginal health. • Support the health of the urinary tract.
Fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
Fem Dophilus 60 Capsule
Serving Size: 1 Capsule
Amount per serving
% Daily* Value
Total Probiotic Bacteria:
Lactobacillus rhamnosus GR-1™
Lactobacillus reuteri RC-14®
**Daily value not established.
Other Ingredients: Dextrose anhydrate, potato starch, microcrystalline cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no preservatives, no peanuts/tree nuts.
Suggested Use: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed, or take as directed by your qualified health care consultant.
*Statements on this site have not been evaluated by the Food and Drug Administration.
Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice.
The majority of the product information has been reprinted from the manufacturer.